Cargando…

Secondary debulking for ovarian carcinoma relapse: The R-R dilemma – is the prognosis different for residual or recurrent disease?

OBJECTIVE: To analyze the kind of ovarian cancer relapse by separating residual from recurrent disease and correlating them with patient survival. MATERIAL AND METHODS: This was a retrospective study of 200 women with ovarian carcinoma relapse between 2005 and 2017. RESULTS: The main sites of residu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spiliotis, John D., Iavazzo, Christos, Kopanakis, Nikolaos D., Christopoulou, Athina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883755/ https://www.ncbi.nlm.nih.gov/pubmed/31362486 http://dx.doi.org/10.4274/jtgga.galenos.2019.2018.0165

Ejemplares similares

Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC
por: Iavazzo, Christos, et al.
Publicado: (2020)

Spiliotis-Farfarelos Maneuver for the Management of Small Bowel Obstruction and Frozen Pelvis in Patients With Peritoneal Metastasis
por: Spiliotis, John, et al.
Publicado: (2022)

CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival
por: Spiliotis, John, et al.
Publicado: (2019)

Safety and feasibility of robotic surgery in selected ovarian cancer patients undergoing interval debulking surgery
por: Iavazzo, Christos, et al.
Publicado: (2020)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

Parameters affecting outcomes of transumbilical and periumbilical median incisions in ovarian cancer patients
por: Iavazzo, Christos, et al.
Publicado: (2023)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
por: Cornali, Tommaso, et al.
Publicado: (2017)

Endometrioid endometrial cancer treated with open or laparoscopic approach: is there a dilemma?
por: Iavazzo, Christos, et al.
Publicado: (2023)

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in FIGO Stage III and IV Epithelial Ovarian, Tubal or Peritoneal Cancer: A Systematic Review and Meta-Analysis
por: Tzanis, Alexander A., et al.
Publicado: (2022)

Quinary debulking for epithelial ovarian cancer
por: Edwards, James M., et al.
Publicado: (2012)

Preservation of Ovarian Reserve after Laparoscopic Cystectomy
por: Iavazzo, Christos, et al.
Publicado: (2022)

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
por: Bååth, Maria, et al.
Publicado: (2020)

Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
por: Nakamura, Kazuto, et al.
Publicado: (2020)

The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
por: Yang, Shi‐Ping, et al.
Publicado: (2022)

Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer
por: Arab, Maliheh, et al.
Publicado: (2018)

Does Endometriosis Hinder Successful Ovarian Debulking Surgery?
por: Sananpanichkul, Panya, et al.
Publicado: (2018)

The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer
por: Kawahara, Naoki, et al.
Publicado: (2022)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

A Validation Study of Administrative Claims Data to Measure Ovarian Cancer Recurrence and Secondary Debulking Surgery
por: Livaudais-Toman, Jennifer, et al.
Publicado: (2016)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery
por: Fagotti, A, et al.
Publicado: (2016)

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)
por: Hirakawa, Tomoko, et al.
Publicado: (2017)

Diaphragm hernia after debulking surgery in patients with ovarian cancer
por: Ehmann, Sarah, et al.
Publicado: (2021)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer
por: Nakayama, Naomi, et al.
Publicado: (2022)

The Role of Robotics in Ovarian Transposition
por: Iavazzo, Christos, et al.
Publicado: (2013)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
por: Günakan, Emre, et al.
Publicado: (2020)

Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
por: Yokosu, Kota, et al.
Publicado: (2021)

Postoperative paralytic ileus following debulking surgery in ovarian cancer patients
por: Egger, Eva K., et al.
Publicado: (2022)

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023)

Septic Shock Secondary to Tricuspid Valve Vegetation Requiring Surgical Debulking
por: Gorantla, Asher, et al.
Publicado: (2023)

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer
por: Vitarello, John, et al.
Publicado: (2021)

Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer
por: Derlatka, Pawel, et al.
Publicado: (2016)

Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
por: Tsoi, Tung Tung, et al.
Publicado: (2020)

Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
por: Psomiadou, Victoria, et al.
Publicado: (2021)

Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study
por: Wang, Dengfeng, et al.
Publicado: (2021)

Characterization of the cluster MabR prophages of Mycobacterium abscessus and Mycobacterium chelonae
por: Cote, Jacob, et al.
Publicado: (2022)

Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
por: Christie, Alan, et al.
Publicado: (2013)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7g3jnrpgk2cv9e55q4n0t76ioc